KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) EPS (Basic) (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed EPS (Basic) for 17 consecutive years, with $26.41 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 203.29% to $26.41 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.67 through Dec 2025, up 142.57% year-over-year, with the annual reading at $27.87 for FY2025, 142.64% up from the prior year.
  • EPS (Basic) for Q4 2025 was $26.41 at Bio-Rad Laboratories, up from -$12.7 in the prior quarter.
  • The five-year high for EPS (Basic) was $131.8 in Q3 2021, with the low at -$112.5 in Q1 2022.
  • Average EPS (Basic) over 5 years is -$1.85, with a median of $2.99 recorded in 2023.
  • The sharpest move saw EPS (Basic) tumbled 442.36% in 2022, then skyrocketed 540.27% in 2024.
  • Over 5 years, EPS (Basic) stood at -$52.54 in 2021, then surged by 153.08% to $27.89 in 2022, then crashed by 56.44% to $12.15 in 2023, then crashed by 310.45% to -$25.57 in 2024, then surged by 203.29% to $26.41 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $26.41, -$12.7, and $11.67 for Q4 2025, Q3 2025, and Q2 2025 respectively.